Stocktoria
Coya Therapeutics, Inc. COYA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-12-29
Coya Therapeutics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -283.9% | -485.4% | -131.7% | — | — |
| Net margin | -267.1% | -418.7% | -133.1% | — | — |
| Return on assets | -42.5% | -33.6% | -19.4% | -145.8% | -102.1% |
| Return on equity | -49.3% | -37.6% | -22.4% | 145.9% | -134.3% |
| Current ratio | 8.50 | 11.59 | 8.15 | 1.88 | 3.99 |
| Revenue growth | 123.6% | -40.8% | — | — | — |
Source: SEC EDGAR filings · CIK 0001835022 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.